Utah Medical Products Inc (UTMD) earnings date, market-implied expected move, and options open interest by expiry

earnings room

74.32+0.49%

Next report

fiscal Q3 2026

Nov 10

timing tbd · estimated date

days out

Intraday

No intraday reading yet this session.

Revenue flow

Q2 FY2026 as filed · change vs Q1 FY2026

UTMD kept 31.49% of Q2 FY2026 revenue as profit. Revenue −2.21% on Q1 FY2026, −14.31% on Q2 FY2025.

Revenue$9M

Gross profit$5M55.79%

Operating income$3M31.06%

Pre-tax income$3M

Net income$3M31.49%

Cost of revenue

$4M · 44.21%

Operating expenses

$2M · 24.73%

Tax

$600,000 · 7.03%

Other income joins

$637,000 · 7.47%

Standardized lines from UTMD’s own filing for the quarter ended Jun 30 '26. Ribbon thickness is the dollar amount.

Expected move

No options chain priced for this ticker yet.

Linked exposure

placeholder

No linked names measured for this ticker yet.

Positioning

placeholder

No options positioning captured for this ticker yet.

Earnings history

implied in pale · realized in full ink

Q2 FY26—

−7.24%—

Apr 23 '26—

−2.53%—

Jan 29 '26—

+1.33%—

Oct 23 '25—

−0.93%—

Jul 24 '25—

−0.21%—

Apr 29 '25—

+0.56%—

Show older reports· 2

Jan 28 '25—

−1.82%—

Oct 29 '24—

−0.14%—

3-quarter memory

Event sensitivity

release-day history · not a forecast

FOMCrate decision1.2×up 9 of 24±1.3% vs ±1.1% · 24
NFPjobs report1.0×up 5 of 9±1.1% vs ±1.1% · 9
PPIproducer prices0.9×up 7 of 9±1.0% vs ±1.1% · 9
CPIconsumer prices0.8×up 5 of 9±0.9% vs ±1.1% · 9
PCEpersonal income & outlays0.8×up 11 of 18±0.9% vs ±1.1% · 18
GDPgross domestic product0.8×up 9 of 18±0.9% vs ±1.1% · 18
CPROFcorporate profits0.7×up 7 of 11±0.8% vs ±1.1% · 11

Past release days against UTMD’s ordinary ±1.1% day, from our own stored closes. History, not a forecast; kinds with fewer than six releases are omitted.

Track UTMD

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.